HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicolas Bidère Selected Research

Antigen Receptors (Antigen Receptor)

1/2020Paracaspase MALT1 regulates glioma cell survival by controlling endo-lysosome homeostasis.
1/2018Post-translational Modifications of the CARMA1-BCL10-MALT1 Complex in Lymphocytes and Activated B-Cell Like Subtype of Diffuse Large B-Cell Lymphoma.
4/2014A catalytic-independent role for the LUBAC in NF-κB activation upon antigen receptor engagement and in lymphoma cells.
3/2009Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival.
3/2005Requirement for caspase-8 in NF-kappaB activation by antigen receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicolas Bidère Research Topics

Disease

7Neoplasms (Cancer)
01/2019 - 05/2007
4Glioblastoma (Glioblastoma Multiforme)
11/2021 - 01/2014
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2020 - 08/2006
3Lymphoma (Lymphomas)
01/2016 - 03/2009
2Inflammation (Inflammations)
01/2021 - 10/2019
2Virus Diseases (Viral Diseases)
05/2012 - 03/2007
2Autoimmune Lymphoproliferative Syndrome
01/2006 - 03/2005
1Glioma (Gliomas)
01/2020
1Necrosis
10/2019
1Squamous Cell Carcinoma of Head and Neck
01/2019
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018
1Kaposi Sarcoma (Kaposi's Sarcoma)
02/2015
1Latent Infection
02/2015
1Chediak-Higashi Syndrome
08/2002

Drug/Important Bio-Agent (IBA)

5Antigen Receptors (Antigen Receptor)IBA
01/2020 - 03/2005
4Transcription Factors (Transcription Factor)IBA
01/2018 - 03/2005
2UbiquitinIBA
01/2021 - 01/2019
2Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA
01/2020 - 08/2006
2Phosphotransferases (Kinase)IBA
10/2019 - 08/2006
2Proteins (Proteins, Gene)FDA Link
10/2019 - 01/2018
2CytokinesIBA
10/2019 - 05/2012
2EnzymesIBA
01/2018 - 01/2016
2Monomeric GTP-Binding ProteinsIBA
02/2015 - 05/2007
2NF-kappa B (NF-kB)IBA
03/2009 - 03/2005
2Caspase 8 (Caspase-8)IBA
03/2007 - 08/2006
1von Willebrand FactorIBA
11/2021
1Peptide Hydrolases (Proteases)FDA Link
01/2020
1Interleukin-8 (Interleukin 8)IBA
10/2019
1NexusIBA
10/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019
1Deubiquitinating EnzymesIBA
01/2019
1EverolimusFDA Link
01/2019
1Conditioned Culture MediaIBA
01/2019
1Temozolomide (Temodar)FDA LinkGeneric
12/2018
1EscinIBA
10/2016
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
02/2015
1Oxygen (Dioxygen)IBA
01/2014
1MitogensIBA
01/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2014
1Viral RNAIBA
05/2012
1Antiviral Agents (Antivirals)IBA
05/2012
1Interferon Type IIBA
05/2012
1Casein Kinases (Casein Kinase)IBA
03/2009
1Proto-Oncogene Proteins p21(ras)IBA
05/2007
1CaspasesIBA
01/2006
1Toll-Like Receptor 4IBA
03/2005
1Fc Receptors (Fc Receptor)IBA
03/2005
1Caspase 3 (Caspase-3)IBA
08/2002
1PerforinIBA
08/2002
1Serine Proteases (Serine Protease)IBA
08/2002

Therapy/Procedure

1Therapeutics
01/2018